SOPHiA GENETICS Q4 revenue up 22% YoY to $21.7 mln, FY22 revenue up 19% YoY to $77.3 mln.

• SOPHiA GENETICS Q4 revenue up 22% YoY to $21.7mln. • Gross margin 67.7% on reported basis, 73.9% on adjusted basis. • IFRS net loss $19.2mln, up 27% YoY; adjusted EBITDA loss $9.9mln, up 9% YoY. • FY2025 revenue up 19% YoY to $77.3mln. • Gross margin 67.4% on reported basis, 74.2% on adjusted basis. • IFRS net loss $79mln, up 26% YoY; adjusted EBITDA loss $41.5mln, up 3% YoY.